the most appropriate design for exposure causing adverse events of rare disorders. Case-control studies begin with the outcome of interest, and typically look retrospectively for differences in exposure.
Thus patients with and without meningioma were identified and asked about their history of dental x-rays.
One of the main problems with case-control studies is the selection of the control group, and the authors appropriately selected controls at random and matched them with cases by age, gender and geographic location. However, there were a number of methodological and statistical problems with this study, which makes interpreting results quite difficult. Perhaps the most glaring issue in this study involves recall or memory bias. This is when patients are asked about their history of a particular exposure. Patients' memory of exposures such as dental x-rays have generally been shown to be quite unreliable, especially when asked about events that may have occurred in the distant past. To combat recall bias, the authors should have attempted to use dental records, rather than relying on patients' memory of radiation history. While dental records are not perfect, they would have been more reliable than patient memory. Additionally, patient interviews were by telephone for 52 minutes. A face-to-face interview would seem to have elicited more trustworthy answers.
Regarding statistical analysis, running statistical tests on baseline data is inappropriate. Statistical tests were not set-up to find differences at baseline; they are designed to detect differences at the end of the study period. Furthermore, non-significant differences do not mean that groups were not actually different, although they appeared to be similar as reported in Table 1 of the study. Additionally, running multiple statistical tests without a correction factor inflates the chances of a type I error, or falsely rejecting the null hypothesis, and this study ran over 40 odds ratios. Therefore, the likelihood of a type
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Case/Control Selection Cases consisted of individuals who had histologically confirmed intracranial meningioma form the states of Connecticut, Massachusetts, North Carolina and 6 counties in the state of California. The control group were selected using random-digitdialing and matched to cases by 5-year age interval, sex, and state of residence. Information was collected from consenting participants by telephone interview. The sample that was used in this analysis included 1433 cases and 1350 controls.
Data Analysis Descriptive statistics were used to examine associations between the risk of meningioma and independent covariates.
Conditional logistic regression was used to assess the odds of meningioma associated with risk factors.
Results The authors reported an odds ratio of 2.0 (95%CI 1.4-2.9), meaning patients with meningioma (cases) had double the odds of reporting ever having a bitewing x-ray as compared with non-disease controls. Individuals who reported receiving bitewing x-rays on a yearly or more frequent basis had an elevated odds as age increased. An increased risk of meningioma also was associated with panorex films taken at a young age.
Conclusions Exposure to some dental x-rays in the past, especially when radiation exposure was greater than it is currently, is associated with increased risk of meningioma. As with other sources of ionizing radiation, limiting its use may be a benefit to patients.
Question Can exposure from dental x-rays increase the risk of meningioma?
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Panorex-any age' (OR 1.0 95%CI 0.8-1.2). This also raises the question of biologic plausibility: how is it that significant results were obtained for a single bitewing x-ray, yet results were nonsignificant for roughly 15 times the radiation with full mouth x-rays? One could also question the meaning of an odds ratio of '2'. While doubling the odds seems ominous, doubling a rare event means the event is still uncommon. Thus, doubling a baseline risk of meningioma from 0.007% to 0.014%, while undesirable, may not necessarily represent a clinically significant increase in health risk.
The data in Table 2 of the study were difficult to reproduce.
Simple percentages did not always compute, and even though odds ratios were adjusted, they don't approximate unadjusted calculations, and the authors should have provided clarification for this phenomenon.
Determining an appropriate sample size is important in scientific investigations. Too large a sample can result in small differences between groups which are often clinically irrelevant yet statistically significant. This study did not mention a power calculation, and with roughly 1300 participants per group, it's possible that this study was over-powered. An appropriate sample size may have provided non-significant results for most outcomes. Additionally, bigger is not always better in observational study designs, where data management can be problematic.
A regression analysis was done but there were several problems with it. For example, controls were matched with cases for age and gender, and running a logistic regression analysis on these same covariates used to match cases will not allow detection of such differences.1 The regression analysis should have examined covariates such as smoking or lifestyle on meningioma. In other words, was it possible that meningioma patients had poorer overall health, thus being at risk for more general health problems, including cancer?
In general, even in the best of circumstances, observational studies can produce spurious results due to issues with bias and confounders. However, a case-control study is the appropriate design to detect differences in exposure between patients with and without the outcome of interest. While it is generally agreed that exposure to artificial sources of radiation should be kept to a minimum, the numerous methodological and statistical issues present appear to render the study results unreliable.
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